Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tiratricol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 11/20 | 1.00 |
| ▸ | THRA known ✓ | P10827 | 9/20 | 1.00 |
| ▸ | PCNA | P12004 | 9/20 | 1.00 |
| ▸ | PPARG | P37231 | 4/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 3/20 | 1.00 |
| ▸ | RXRA | P19793 | 2/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | GABRA1 | P14867 | 2/20 | 1.00 |
| ▸ | GABRA2 | P47869 | 2/20 | 1.00 |
| ▸ | GABRB2 | P47870 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | PGR | P06401 | 1/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | HTR1A | P08908 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tiratricol SCHEMBL30161572 | 1.00 | THRB (1.00) | THRBPCNATHRAPPARGLMNA | |
| Tiratricol SCHEMBL743426 | 1.00 | THRB (1.00) | THRBPCNATHRAPPARGLMNA | |
| Tiratricol SCHEMBL8660328 | 0.99 | THRB (0.97) | THRBPCNATHRAPPARGLMNA | |
| Tiratricol SCHEMBL10701956 | 0.99 | THRB (0.97) | THRBPCNATHRAPPARGLMNA | |
| Tiratricol SCHEMBL2671904 | 0.99 | THRB (0.97) | THRBPCNATHRAPPARGLMNA | |
| SCHEMBL18573065 | 0.91 | THRB (0.82) | THRBPCNATHRAPPARGLMNA | |
| Tiratricol SCHEMBL5881667 | 0.90 | THRB (0.81) | THRBPCNATHRAPPARGLMNA | |
| Tiratricol SCHEMBL21624999 | 0.88 | THRB (0.77) | THRBPCNATHRAPPARGLMNA | |
| Tiratricol SCHEMBL9296273 | 0.88 | THRB (0.77) | THRBPCNATHRAPPARGLMNA | |
| SCHEMBL5858371 | 0.87 | THRB (0.78) | THRBPCNATHRAPPARGLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 59097 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6434024-B1 | — | — | None | — | — | US | claimed |
| US-20260053761-A1 | USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER | UNIV OF VERMONT AND STATE AGRICULTURAL COLLEGE (US) | 2026-02-26 | — | — | US | claimed |
| US-20250304916-A1 | METHODS AND COMPOSITIONS FOR GENERATING VASCULAR LEPTOMENINGEAL CELLS | TRAILHEAD BIOSYSTEMS INC (US) | 2025-10-02 | — | — | US | claimed |
| EP-4569090-A2 | METHODS AND COMPOSITIONS FOR GENERATING OLIGODENDROCYTE PROGENITOR CELLS | Trailhead Biosystems Inc. (US) | 2025-06-18 | — | — | EP | claimed |
| EP-4561704-A2 | USE OF GLYCOGEN METABOLISM INHIBITORS FOR THE TREATMENT OF CANCER | The University Of Vermont (US) | 2025-06-04 | — | — | EP | claimed |
| EP-4129280-B1 | TRIAC (3,3',5-TRIIODOTHYROACETIC ACID) FOR USE IN TREATING ALPHA-THALASSEMIA | SHANGHAI SPH RARE DISEASE PHARMACEUTICAL CO LTD (CN) | 2025-02-05 | — | — | EP | claimed |
| US-20240400672-A1 | NOVEL MONOCLONAL ANTIBODIES DIRECTED AGAINST L-THYROXINE AND DIAGNOSTIC USES THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2024-12-05 | — | — | US | claimed |
| CN-119055625-A | Tiratricol use as ADV7 virus inhibitor | 湖北工业大学 | 2024-12-03 | — | — | CN | claimed |
| EP-4430074-A1 | NOVEL MONOCLONAL ANTIBODIES DIRECTED AGAINST L-THYROXINE AND DIAGNOSTIC USES THEREOF | F. Hoffmann-La Roche AG (CH) | 2024-09-18 | — | — | EP | claimed |
| US-20240263135-A1 | COMPOSITIONS AND METHODS FOR IMMUNE CELL MODULATION IN ADOPTIVE IMMUNOTHERAPIES | FATE THERAPEUTICS, INC. | 2024-08-08 | — | — | US | claimed |
| US-3938940-A | Primary control and ignition system for oil burners | ROBERTSHAW CONTROLS COMPANY (US) | 1976-02-17 | — | — | US | claimed |
| US-3939358-A | Plural load lighting assembly energizable through two input terminals | SAVEKER JAMES A | 1976-02-17 | — | — | US | claimed |
| US-3937989-A | Temperature discrimination apparatus | MULTI-STATE DEVICES LTD. (CA) | 1976-02-10 | — | — | US | claimed |
| US-3935522-A | Control device for the electric fan | TSAY PETER WEN TIEN | 1976-01-27 | — | — | US | claimed |
| US-3935561-A | Signal lamp configuration for directing high speed traffic and sequencing means therefor | F. B. ELECTRONICS (US) | 1976-01-27 | — | — | US | claimed |
| US-3934156-A | Movement responsive control apparatus | COLONIAL KINETICS, INC. (US) | 1976-01-20 | — | — | US | claimed |
| US-3933140-A | Capacitive discharge ignition adapter | SYNCRO CORPORATION (US) | 1976-01-20 | — | — | US | claimed |
| US-3932770-A | Control circuit for switching triacs | XEROX CORPORATION (US) | 1976-01-13 | — | — | US | claimed |
| US-3932789-A | Current sensing protector system for A. C. motors | DETPROTECTOR, INC. (US) | 1976-01-13 | — | — | US | claimed |
| US-3930783-A | PRIMARY CONTROL MEANS FOR FURNACES | ROBERTSHAW CONTROLS COMPANY (US) | 1976-01-06 | — | — | US | claimed |